Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christopher P. Barrozo is active.

Publication


Featured researches published by Christopher P. Barrozo.


Journal of Clinical Microbiology | 2004

Risk Factors for Community-Associated Methicillin-Resistant Staphylococcus aureus Infections in an Outbreak of Disease among Military Trainees in San Diego, California, in 2002

Katherine M. Campbell; Andrew F. Vaughn; Kevin L. Russell; Besa Smith; Dinice L. Jimenez; Christopher P. Barrozo; John R. Minarcik; Nancy F. Crum; Margaret A. K. Ryan

ABSTRACT An outbreak of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections was observed in a population of U.S. military trainees in the summer of 2002. A questionnaire was developed and administered to 206 trainees, 22 of whom had MRSA infections. Factors associated with infection were described by multivariable logistic regression modeling and included having a roommate in training with a prior skin infection (odds ratio [OR] = 3.44) or having a family member or friend who worked in a health care setting (OR = 2.79). Previous antibiotic use, hospitalization, or health problems were not associated with MRSA infection. This outbreak of MRSA skin infections in an otherwise-healthy, well-defined, military population provided an opportunity to describe risk factors for CA-MRSA which may help focus prevention efforts in this and other communities.


Journal of Clinical Microbiology | 2005

Use of Resequencing Oligonucleotide Microarrays for Identification of Streptococcus pyogenes and Associated Antibiotic Resistance Determinants

Louis Davignon; Elizabeth A. Walter; Kate M. Mueller; Christopher P. Barrozo; David A. Stenger; Baochuan Lin

ABSTRACT Group A streptococci (GAS) are responsible for a wide variety of human infections associated with considerable morbidity and mortality. Ever since the first systematic effort by Lancefield to group Streptococcus species by M protein variants, the detection and characterization of Streptococcus by different methods have been an evolving process. The ideal assay for GAS identification not only would provide quick and accurate diagnostic results but also would reveal antibiotic resistance patterns and genotype information, aiding not only in treatment but in epidemiologic assessment as well. The oligonucleotide microarray is a promising new technology which could potentially address this need. In this study, we evaluated the usefulness of oligonucleotide resequencing microarrays for identifying GAS and its associated antibiotic resistance markers. We demonstrated an assay platform that combines the use of resequencing DNA microarrays with either random nucleic acid amplification or multiplex PCR for GAS detection. When detecting Streptococcus pyogenes from coded clinical samples, this approach demonstrated an excellent concordance with a more established culture method. To this end, we showed the potential of resequencing microarrays for efficient and accurate detection of GAS and its associated antibiotic resistance markers with the benefit of sequencing information from microarray analysis.


Clinical Infectious Diseases | 2004

An Outbreak of Conjunctivitis Due to a Novel Unencapsulated Streptococcus pneumoniae among Military Trainees

Nancy F. Crum; Christopher P. Barrozo; Frank A. Chapman; Margaret A. K. Ryan; Kevin L. Russell

BACKGROUND Bacterial conjunctivitis usually occurs as sporadic cases; outbreaks are uncommon and usually are associated with school campuses. We report an outbreak of Streptococcus pneumoniae conjunctivitis at a military training facility. METHODS An outbreak investigation was done. Each case of conjunctivitis was evaluated with an assessment tool including demographic and clinical data. Conjunctival swabs were obtained. Pneumococci underwent standard testing, including serotyping with the Quellung reaction, capsular staining, and multilocus sequence typing. Sequence types were compared with previous reported outbreak strains by construction of dendrograms. Carriage rates of S. pneumoniae were determined among previously undiagnosed case patients with conjunctivitis, and a case-control study was performed. Control measures included education to increase hand washing, distribution of alcohol-based hand gel, and prompt treatment of patients with conjunctivitis. RESULTS During a 6-week period, 92 cases of conjunctivitis occurred among 3500 persons, with an attack rate of 1.75 cases per 100 person-months. Eighty cases (87%) were due to S. pneumoniae; 45 (49%) were confirmed, and 35 (38%) were probable. Ten percent of recruits surveyed carried the outbreak strain. Twenty-two percent self-reported symptoms consistent with conjunctivitis during the outbreak period; sharing washcloths was associated with conjunctivitis (odds ratio, 11.7; P=.03). The causative organism was resistant to azithromycin but susceptible to telithromycin. The outbreak strain was an unencapsulated S. pneumoniae that has not been previously described; it was most closely related to the sequence type causing the Dartmouth College (Hanover, NH) outbreak of conjunctivitis in 2002. CONCLUSIONS We report a conjunctivitis outbreak among military trainees caused by a novel, unencapsulated strain of S. pneumoniae.


Journal of Clinical Microbiology | 2003

National Department of Defense Surveillance Data for Antibiotic Resistance and emm Gene Types of Clinical Group A Streptococcal Isolates from Eight Basic Training Military Sites

Christopher P. Barrozo; Kevin L. Russell; Tyler C. Smith; Anthony W. Hawksworth; Margaret A. K. Ryan; Gregory C. Gray

ABSTRACT Antibiotic resistance and emm gene types were examined from 692 Group A streptococci isolates from eight United States military basic training sites between 1998 and 2001. Macrolide resistance was associated with geographic sites and emm type. These data are useful for vaccine development initiatives and antimicrobial treatment considerations.


The Journal of Infectious Diseases | 2001

National Department of Defense Surveillance for Invasive Streptococcus pneumoniae: Antibiotic Resistance, Serotype Distribution, and Arbitrarily Primed Polymerase Chain Reaction Analyses

Marie K. Hudspeth; Tyler C. Smith; Christopher P. Barrozo; Anthony W. Hawksworth; Margaret A. K. Ryan; Gregory C. Gray

To provide surveillance among US military personnel and their beneficiaries, 157 invasive Streptococcus pneumoniae clinical isolates were collected systematically from 7 large military hospitals between August 1997 and August 1999. The isolates were studied for antibiotic resistance, and 120 were serotyped and subjected to arbitrarily primed polymerase chain reaction (AP-PCR). Fifty (31.9%) of 157 isolates had intermediate or high-level resistance to penicillin, and 15.9% had multidrug resistance. The most common serotypes were 4, 6B, 9V, 14, 19F, and 23F. Those serotypes associated with penicillin resistance were 6B, 9V, 19A, and 19F. Most invasive disease cases were caused by serotypes included in the currently available 23- and 7-valent pneumococcal vaccines. By use of AP-PCR, 4 DNA groups were correlated with health care site (P< or =.0001). These results are valuable in assessing appropriate use of antibiotics and vaccines against S. pneumoniae in both military personnel and their families.


Clinical Infectious Diseases | 2001

Randomized, placebo-controlled clinical trial of oral azithromycin prophylaxis against respiratory infections in a high-risk, young adult population.

Gregory C. Gray; Peter J. Witucki; Mark T. Gould; Stephen J. Bell; Katia M. Hiliopoulos; Jamie A. McKeehan; Julie M. Fuller; Christopher P. Barrozo; Marie K. Hudspeth; Tyler C. Smith; Elizabeth K. Ledbetter; Mark R. Wallace

Military Special Forces trainees undergo intense psychological and physical stressors that often lead to respiratory infection. During 1998-2000, 477 Navy Special Forces trainees were enrolled in a double-blind trial of oral azithromycin (1 g given weekly) plus a placebo injection, compared with benzathine penicillin G (1.2 million U) plus azithromycin placebo tablets. Among the 464 subjects with complete data, 44 developed acute respiratory infection (20 with pneumonia) during the 2 weeks of most intense training; of these subjects, 12 (27.3%) had evidence of Chlamydia pneumoniae infection and 7 (15.9%) had evidence of Mycoplasma pneumoniae infection. Trainees who received azithromycin were less likely than were trainees who received benzathine penicillin G to develop acute respiratory infection (risk ratio, 0.50; 95% confidence interval [CI], 0.28-0.92) and less likely at the end of training to report episodes of breathing difficulty (odds ratio [OR], 0.59; 95% CI, 0.34-1.01) or sore throat (OR, 0.66; 95% CI, 0.41-1.05). Compared with benzathine penicillin G prophylaxis, weekly oral azithromycin was superior in preventing respiratory infection in this population at transient high risk.


BMC Infectious Diseases | 2005

Fatal meningitis in a previously healthy young adult caused by Streptococcus pneumoniae serotype 38: an emerging serotype?

Carolyn I. Baker; Christopher P. Barrozo; Margaret A. K. Ryan; Lisa A. Pearse; Kevin L. Russell

BackgroundIn December 2001, a fatal case of pneumococcal meningitis in a Marine Corps recruit was identified. As pneumococcal vaccine usage in recruit populations is being considered, an investigation was initiated into the causative serotype.Case presentationTraditional and molecular methods were utilized to determine the serotype of the infecting pneumococcus. The pneumococcal isolate was identified as serotype 38 (PS38), a serotype not covered by current vaccine formulations. The global significance of this serotype was explored in the medical literature, and found to be a rare but recognized cause of carriage and invasive disease.ConclusionThe potential of PS38 to cause severe disease is documented in this report. Current literature does not support the hypothesis that this serotype is increasing in incidence. However, as we monitor the changing epidemiology of pneumococcal illness in the US in this conjugate era, PS38 might find a more prominent and concerning niche as a replacement serotype.


Molecular and Cellular Probes | 2005

A Multiplex PCR for Detection of Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila, and Bordetella pertussis in Clinical Specimens

Erin A. McDonough; Christopher P. Barrozo; Kevin L. Russell; David Metzgar


Journal of Antimicrobial Chemotherapy | 2005

Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998–2003

Momtaz O. Wasfy; Guillermo Pimentel; Mohammed S. Abdel-Maksoud; Kevin L. Russell; Christopher P. Barrozo; John D. Klena; Kenneth C. Earhart; Rana Hajjeh


International Journal of Antimicrobial Agents | 2004

Streptococcus pneumoniae in Saudi Arabia: antibiotic resistance and serotypes of recent clinical isolates

Ziad A. Memish; Hanan H. Balkhy; Atef M. Shibl; Christopher P. Barrozo; Gregory C. Gray

Collaboration


Dive into the Christopher P. Barrozo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Margaret A. K. Ryan

California Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Tyler C. Smith

United States Department of Defense

View shared research outputs
Top Co-Authors

Avatar

David Metzgar

Naval Medical Center San Diego

View shared research outputs
Top Co-Authors

Avatar

Margaret A. Ryan

Naval Medical Center San Diego

View shared research outputs
Top Co-Authors

Avatar

Nancy F. Crum

Naval Medical Center San Diego

View shared research outputs
Top Co-Authors

Avatar

Baochuan Lin

United States Naval Research Laboratory

View shared research outputs
Top Co-Authors

Avatar

Besa Smith

Naval Medical Center San Diego

View shared research outputs
Top Co-Authors

Avatar

David A. Stenger

United States Naval Research Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge